Internal Medicine

3151 questions

Question 981Question →

Emergency medical personnel transport an elderly resident from an assisted living facility to the acute medical unit. The staff reported a three-day decline in functional status, noting increased thirst, frequent urination, and an escalating, non-productive cough. Medical records indicate long-standing insulin-requiring diabetes mellitus and severe chronic obstructive pulmonary disease.

Upon arrival, the patient is somnolent but appropriately follows simple commands. Vital signs reveal a temperature of 37.0°C (98.6°F), heart rate of 118/min, blood pressure of 105/62 mm Hg, and a respiratory rate of 28/min with shallow, labored breathing. Oxygen saturation is 90% on ambient air. Physical examination demonstrates poor skin turgor, prominent use of accessory muscles of respiration, and diffuse expiratory wheezing with a prolonged expiratory phase. Jugular venous pressure is estimated at 4 cm H2O.

Initial laboratory studies are obtained:

TestResult
Serum sodium134 mEq/L
Serum potassium4.9 mEq/L
Serum chloride96 mEq/L
Serum bicarbonate12 mEq/L
Blood urea nitrogen42 mg/dL
Serum creatinine1.8 mg/dL
Serum glucose540 mg/dL

Arterial blood gas analysis on ambient air:

TestResult
pH7.15
PaCO238 mm Hg
PaO265 mm Hg

In addition to intravenous fluid resuscitation and a continuous regular insulin infusion, which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiation of noninvasive positive pressure ventilation

Answer

The most appropriate next step is the initiation of noninvasive positive pressure ventilation to address the impending respiratory failure.
The correct answer identifies that this patient is suffering from two concurrent, life-threatening pathologies: diabetic ketoacidosis (DKA) and an acute exacerbation of COPD leading to respiratory failure. The diagnosis of the mixed acid-base disorder hinges on Winter's formula (PaCO2=1.5×[HCO3−]+8±2PaCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2). With a serum bicarbonate of 12 mEq/L, her expected PaCO2PaCO_2 should be between 24 and 28 mm Hg. Because her actual PaCO2PaCO_2 is 38 mm Hg, she has a superimposed respiratory acidosis. In a patient with severe COPD presenting with tachypnea, use of accessory muscles, and somnolence, this relative hypercapnia represents severe respiratory muscle fatigue. While the DKA is being managed with fluids and insulin, the immediate life-threatening respiratory failure must be addressed with noninvasive positive pressure ventilation (NIPPV).

Step-by-Step Solution

1
Calculate the anion gap to determine the primary metabolic disorder.
Anion Gap = 134−(96+12)=26134 - (96 + 12) = 26.
An elevated anion gap (>12>12) confirms a primary metabolic acidosis, consistent with the clinical picture of diabetic ketoacidosis (DKA).
2
Apply Winter's formula to determine if respiratory compensation is adequate.
Expected PaCO2=1.5×12+8±2=26±2PaCO_2 = 1.5 \times 12 + 8 \pm 2 = 26 \pm 2 mm Hg (range 24-28).
To identify mixed acid-base disorders, the expected compensatory PaCO2 must be compared to the measured PaCO2.
3
Compare the expected PaCO2 to the measured PaCO2 from the arterial blood gas.
The measured PaCO2PaCO_2 is 38 mm Hg, which is significantly higher than the expected maximum of 28 mm Hg.
When the measured PaCO2 is higher than the expected value, a concurrent primary respiratory acidosis is present.
4
Correlate the laboratory findings with the clinical examination.
The patient has a history of severe COPD, is using accessory muscles, and is somnolent despite tachypnea.
A "normal" PaCO2 of 38 mm Hg in the setting of severe metabolic acidosis indicates respiratory muscle fatigue and impending respiratory failure. Noninvasive positive pressure ventilation (NIPPV) is the appropriate intervention to provide ventilatory support.

Key Concept

In patients with a primary metabolic acidosis, a 'normal' PaCO2 on arterial blood gas often indicates a failure of respiratory compensation and a concurrent respiratory acidosis, signaling impending respiratory failure that requires ventilatory support.
Estimated Time:2m 0s
Question 982Question →

A 2525-year-old man presents to the clinic with a diffuse maculopapular rash on his trunk, palms, and soles, along with generalized lymphadenopathy. He reports having a painless penile ulcer 22 months ago that resolved on its own. Assuming the traditional testing algorithm is used, arrange the following steps in the most appropriate chronological sequence for the diagnosis and management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for the traditional syphilis management algorithm is: initial screening with a nontreponemal test, followed by confirmation with a treponemal test, targeted treatment with intramuscular benzathine penicillin G, and finally, monitoring for a cure using serial quantitative nontreponemal titers.
The traditional algorithm for diagnosing and managing syphilis follows a strict chronological order. It begins with a nontreponemal test (such as RPR or VDRL) for initial screening. Because these tests have high false-positive rates, any positive result must be confirmed with a specific treponemal test (such as FTA-ABS or TP-PA). Once confirmed, the patient is formally diagnosed with secondary syphilis and treated with the standard regimen: intramuscular benzathine penicillin G. To ensure the treatment was effective and the patient is cured, quantitative nontreponemal titers must be monitored at 66 and 1212 months to observe at least a fourfold decline.

Step-by-Step Solution

1
Identify the suspected disease based on the patient's clinical presentation.
The patient's diffuse maculopapular rash involving the palms and soles, preceded by a painless ulcer (chancre), is classic for secondary syphilis.
Recognizing the clinical stage of the infection guides the subsequent diagnostic and therapeutic approach.
2
Determine the first diagnostic step in the traditional testing algorithm.
The first step is to order a nontreponemal screening test, such as the Rapid Plasma Reagin (RPR) or Venereal Disease Research Laboratory (VDRL) test.
These tests are highly sensitive and inexpensive, making them ideal for initial population screening, though they lack specificity.
3
Determine the necessary follow-up for a positive screening test.
A treponemal confirmatory test, such as Fluorescent Treponemal Antibody Absorption (FTA-ABS) or *Treponema pallidum* particle agglutination (TP-PA), must be performed.
Because nontreponemal tests can yield false-positive results due to cross-reactivity from other conditions, confirmation with a highly specific treponemal test is required before making a definitive diagnosis.
4
Determine the appropriate therapy once the diagnosis of syphilis is confirmed.
The treatment of choice is a single dose of intramuscular benzathine penicillin G.
Penicillin G is the definitive, highly effective first-line treatment for primary, secondary, and early latent syphilis.
5
Determine the appropriate post-treatment follow-up management.
Serial quantitative nontreponemal testing is performed at 66 and 1212 months.
A fourfold decrease in the nontreponemal titer is required to objectively confirm that the treatment was successful.

Key Concept

The traditional diagnostic algorithm for syphilis requires initial screening with a sensitive nontreponemal test, confirmation with a specific treponemal test, targeted treatment with penicillin, and follow-up monitoring of nontreponemal titers.
Estimated Time:1m 0s
Question 983Question →

A 55-year-old man receiving systemic chemotherapy for diffuse large B-cell lymphoma presents to the emergency department with chills and a temperature of 38.8°C (101.8°F). His laboratory evaluation reveals an absolute neutrophil count of 400/mm³. Arrange the following clinical interventions in the correct chronological sequence for the standard initial management of this patient's neutropenic fever.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Obtain blood cultures, followed by administration of empiric broad-spectrum antibiotics, then monitor clinically while awaiting results, and finally narrow the antimicrobial regimen once susceptibilities are known.
The standard of care for febrile neutropenia requires obtaining cultures first so that the causative organism can be identified. Immediately after cultures are drawn, empiric broad-spectrum antibiotics covering Pseudomonas aeruginosa must be given to prevent overwhelming sepsis. The patient is then monitored, and antibiotics are de-escalated to targeted therapy only after specific culture and susceptibility results return.

Step-by-Step Solution

1
Recognize the clinical scenario as neutropenic fever.
The patient has a fever and an absolute neutrophil count < 500/mm³, defining a hematologic/oncologic emergency.
Prompt recognition dictates the urgency of subsequent interventions.
2
Identify the critical first intervention before administering medications.
Blood cultures (both peripheral and central) must be drawn first.
Administering antibiotics before drawing cultures can sterilize the blood samples, preventing the identification of the infecting organism.
3
Determine the next immediate life-saving step.
Administer empiric broad-spectrum intravenous antibiotics (e.g., cefepime).
Patients lack an adequate immune response; delaying antibiotics can lead to rapid clinical deterioration and sepsis.
4
Determine the subsequent hospital course sequence.
Observation and monitoring follow the initial acute resuscitation, leading finally to regimen de-escalation once lab results finalize.
Therapy must be tailored later to prevent antimicrobial resistance and reduce medication toxicity.

Key Concept

In the management of neutropenic fever, blood cultures must be drawn immediately, followed by the rapid administration of broad-spectrum antipseudomonal antibiotics within one hour of presentation, prior to narrowing therapy based on culture results.
Question 984Question →

During a routine follow-up evaluation, a 32-year-old woman with diffuse cutaneous systemic sclerosis reports severe pain and discoloration in her digits. She notes that exposure to cold temperatures triggers her fingers to turn sharply white, then blue, and finally red. Arrange the following therapeutic interventions in the correct step-wise sequence for the management of this patient's Raynaud phenomenon, proceeding from initial conservative measures to therapies reserved for severe, refractory, or tissue-threatening disease.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing secondary Raynaud phenomenon is: non-pharmacologic lifestyle modifications, followed by oral calcium channel blockers, followed by phosphodiesterase-5 inhibitors, and finally intravenous prostanoids for severe tissue-threatening disease.
The standard of care for secondary Raynaud phenomenon involves a precise step-wise escalation. It begins unconditionally with conservative lifestyle modifications, primarily avoiding cold triggers, ensuring whole-body warming, and smoking cessation. If these measures fail to adequately control the frequency or severity of attacks, first-line medical therapy is initiated with dihydropyridine calcium channel blockers (such as nifedipine or amlodipine). Should the patient remain highly symptomatic despite maximally tolerated doses of CCBs, second-line oral agents such as phosphodiesterase-5 inhibitors (e.g., sildenafil) or topical nitrates are added. Finally, for severe, refractory cases presenting with critical digital ischemia or active digital ulcerations, advanced therapies like intravenous prostanoid analogs (iloprost) or endothelin receptor antagonists (bosentan) are utilized.

Step-by-Step Solution

1
Identify the primary clinical presentation.
The patient is presenting with classic triphasic color changes indicative of Raynaud phenomenon, secondary to systemic sclerosis.
Accurate identification of the syndrome dictates the appropriate treatment algorithm.
2
Determine the first-line conservative management.
Cold avoidance and smoking cessation.
All patients must begin with non-pharmacologic lifestyle modifications to minimize triggers before initiating medications.
3
Select the first-line pharmacologic therapy.
Dihydropyridine calcium channel blockers (e.g., nifedipine or amlodipine).
Calcium channel blockers are the standard initial medical therapy for symptomatic relief if lifestyle changes are inadequate.
4
Determine the step-up therapy for refractory symptoms.
Phosphodiesterase-5 inhibitors (e.g., sildenafil).
These agents promote further vasodilation and are indicated when calcium channel blockers alone fail to control symptoms.
5
Identify the intervention for severe, critical ischemia.
Intravenous prostanoids (e.g., iloprost or epoprostenol).
Because of significant side effects and required inpatient administration, these agents are strictly reserved for severe complications like digital ulcers.

Key Concept

Step-wise escalation of therapy for secondary Raynaud phenomenon.
Question 985Question →

A daughter brings her 75-year-old father to the emergency department due to his profound sleepiness and labored breathing over the preceding 72 hours. The patient has developed a worsening cough productive of yellow sputum and subjective fevers during this time. His medical history includes chronic obstructive pulmonary disease (COPD), benign prostatic hyperplasia, and essential hypertension. His home medications are a tiotropium inhaler, as-needed albuterol, and amlodipine.

Vital signs show a temperature of 37.7∘C37.7^\circ\text{C} (99.9∘F99.9^\circ\text{F}), blood pressure of 118/74 mm Hg118/74\text{ mm Hg}, pulse of 108/min108/\text{min}, and respiratory rate of 26/min26/\text{min}. Pulse oximetry reveals an oxygen saturation of 85%85\% on room air.

Physical examination demonstrates a somnolent patient who awakens easily to verbal stimuli and follows simple commands. The anteroposterior chest diameter is increased. Auscultation reveals a prolonged expiratory phase with diffuse wheezing bilaterally, as well as coarse crackles localized to the right lower lung field. Cardiac examination shows a regular tachycardia with distant heart sounds and no murmurs. Trace bilateral ankle edema is present.

Laboratory results are as follows:

Laboratory TestResultReference Range
Leukocyte count14,500/mm314,500/\text{mm}^34,500–11,000/mm34,500\text{--}11,000/\text{mm}^3
Serum sodium136 mEq/L136\text{ mEq/L}136–145 mEq/L136\text{--}145\text{ mEq/L}
Serum potassium4.1 mEq/L4.1\text{ mEq/L}3.5–5.0 mEq/L3.5\text{--}5.0\text{ mEq/L}
Serum chloride94 mEq/L94\text{ mEq/L}98–106 mEq/L98\text{--}106\text{ mEq/L}
Serum bicarbonate35 mEq/L35\text{ mEq/L}22–28 mEq/L22\text{--}28\text{ mEq/L}
Blood urea nitrogen28 mg/dL28\text{ mg/dL}8–20 mg/dL8\text{--}20\text{ mg/dL}
Serum creatinine1.1 mg/dL1.1\text{ mg/dL}0.7–1.3 mg/dL0.7\text{--}1.3\text{ mg/dL}
Thyroid-stimulating hormone (TSH)0.2 μU/mL0.2\text{ }\mu\text{U/mL}0.4–4.0 μU/mL0.4\text{--}4.0\text{ }\mu\text{U/mL}
Free thyroxine (T4)0.7 ng/dL0.7\text{ ng/dL}0.9–1.7 ng/dL0.9\text{--}1.7\text{ ng/dL}

An arterial blood gas analysis obtained on room air demonstrates:

ParameterResult
pH\text{pH}7.257.25
PaO2\text{PaO}_252 mm Hg52\text{ mm Hg}
PaCO2\text{PaCO}_278 mm Hg78\text{ mm Hg}

A portable chest radiograph displays hyperinflated lung fields, flattened hemidiaphragms, and a dense alveolar opacity in the right lower lobe. The cardiac silhouette is normal in size.

Which of the following is the most appropriate next step in management for this patient?

Show answer & explanation

Answer: Initiate noninvasive positive-pressure ventilation and administer intravenous ceftriaxone and azithromycin

Answer

The most appropriate next step is to initiate noninvasive positive-pressure ventilation (NPPV) and administer standard-spectrum antibiotics for community-acquired pneumonia (e.g., ceftriaxone and azithromycin).
This patient is experiencing an acute exacerbation of chronic obstructive pulmonary disease (COPD) complicated by acute-on-chronic hypercapnic respiratory failure, as evidenced by his pH of 7.25 and PaCO2 of 78 mm Hg. In patients with a COPD exacerbation and respiratory acidosis (pH < 7.30), a trial of noninvasive positive-pressure ventilation (NPPV) is the standard of care, provided the patient is not entirely comatose and can protect their airway (this patient awakens easily to verbal stimuli). Furthermore, the clinical picture of fever, purulent sputum, leukocytosis, and a right lower lobe consolidation indicates that community-acquired pneumonia (CAP) is the trigger. Standard inpatient treatment for CAP without risk factors for multidrug-resistant organisms includes a beta-lactam and a macrolide (e.g., ceftriaxone and azithromycin).

Step-by-Step Solution

1
Analyze the arterial blood gas (ABG) and clinical presentation.
The ABG shows a pH of 7.25, PaCO2 of 78 mm Hg, and HCO3 of 35 mEq/L, indicating acute-on-chronic respiratory acidosis. The patient is somnolent but can protect his airway.
Identifying hypercapnic respiratory failure with a pH < 7.30 establishes the immediate need for ventilatory support, with NPPV being the first-line choice for conscious patients.
2
Identify the underlying trigger for the respiratory decompensation.
Fever, leukocytosis, and a right lower lobe opacity on the chest radiograph indicate community-acquired pneumonia (CAP) as the trigger for the COPD exacerbation.
Treating the underlying trigger is essential for resolving the exacerbation.
3
Select the appropriate pharmacologic and supportive therapies.
Standard CAP coverage (e.g., a beta-lactam plus a macrolide) is chosen. Broad-spectrum agents, diuretics, or thyroid hormones are excluded.
There are no risk factors for multidrug-resistant organisms, no evidence of acute heart failure, and the thyroid labs reflect euthyroid sick syndrome, which requires no treatment.

Key Concept

Management of acute-on-chronic respiratory acidosis in COPD exacerbations requires NPPV (if the patient can protect their airway) alongside targeted treatment of the underlying trigger (e.g., standard-spectrum antibiotics for community-acquired pneumonia).
Question 986Question →

A 41-year-old woman is brought to the emergency department by her husband due to a 4-day history of profound fatigue, easy bruising, and recurrent nosebleeds. She has no significant past medical history and takes no medications. Vital signs show a temperature of 37.6∘C37.6^\circ \text{C} (99.7∘F99.7^\circ \text{F}), pulse of 110110/min, respirations of 1818/min, and blood pressure of 105/65105/65 mm Hg. Physical examination reveals pale mucous membranes, diffuse petechiae over the trunk and extremities, and continuous oozing of blood from a peripheral intravenous catheter site.

Laboratory studies reveal the following:

* Hemoglobin: 7.67.6 g/dL
* Leukocyte count: 3,200/μL3,200/\mu\text{L}
* Platelet count: 18,000/μL18,000/\mu\text{L}
* Prothrombin time: 2222 seconds
* Activated partial thromboplastin time: 4848 seconds
* Fibrinogen: 8080 mg/dL (Normal: 200200–400400 mg/dL)
* D-dimer: 8,5008,500 ng/mL (Normal: <500< 500 ng/mL)

Peripheral blood smear demonstrates large mononuclear cells with bilobed nuclei and abundant azurophilic granules; several of these cells contain multiple, needle-like eosinophilic inclusion bodies.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administration of all-trans retinoic acid

Answer

Administration of all-trans retinoic acid
This patient's clinical presentation is highly characteristic of acute promyelocytic leukemia (APL) complicated by disseminated intravascular coagulation (DIC). The peripheral smear describes atypical promyelocytes containing multiple Auer rods, which are pathognomonic for APL. APL is unique among leukemias because it frequently presents with a severe, life-threatening coagulopathy (elevated PT/aPTT, low fibrinogen, elevated D-dimer). The most critical initial step in management is the immediate administration of all-trans retinoic acid (ATRA). ATRA overcomes the differentiation block caused by the PML-RARA fusion protein, allowing the neoplastic promyelocytes to mature into functional neutrophils. This rapidly resolves the coagulopathy and dramatically reduces the risk of fatal hemorrhagic complications, such as intracranial hemorrhage. Because early mortality is so high, ATRA must be started upon clinical suspicion alone, prior to genetic or bone marrow confirmation.

Step-by-Step Solution

1
Analyze the patient's presentation and laboratory findings.
The patient has severe bleeding, pancytopenia, and a coagulation profile consistent with disseminated intravascular coagulation (DIC): prolonged PT/aPTT, low fibrinogen, and markedly elevated D-dimer.
Identifying DIC is critical as it indicates a life-threatening, systemic consumptive coagulopathy.
2
Interpret the peripheral blood smear results.
The presence of large mononuclear cells with bilobed nuclei and multiple needle-like eosinophilic inclusion bodies (Auer rods) indicates acute promyelocytic leukemia (APL).
Auer rods are specific for myeloblasts and promyelocytes; multiple Auer rods ('faggot cells') are pathognomonic for APL.
3
Determine the pathogenesis of the coagulopathy.
The abnormal promyelocytes contain azurophilic granules that, when released, activate the coagulation cascade leading to severe DIC.
Understanding the mechanism dictates why standard cytolytic chemotherapy would be acutely dangerous.
4
Prioritize interventions.
Select immediate administration of all-trans retinoic acid (ATRA) over obtaining a definitive bone marrow biopsy.
Because APL-associated DIC carries an exceptionally high risk of early hemorrhagic death (e.g., intracranial hemorrhage), targeted treatment (ATRA) must begin based on clinical and peripheral smear suspicion alone, without waiting for cytogenetic confirmation.

Key Concept

In patients with suspected acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) must be administered immediately—prior to bone marrow biopsy confirmation—to rapidly reverse the life-threatening coagulopathy of disseminated intravascular coagulation (DIC).
Estimated Time:1m 30s
Question 987Question →

Correlate each complex clinical scenario with the specific autoantibody marker that best corresponds to the patient's underlying rheumatologic diagnosis.

Click a left item, then click its matching right item

Items

A previously healthy individual develops rapidly progressive, profound proximal weakness and severe dysphagia over three weeks. Laboratory analysis reveals a creatine kinase level of 14,500 U/L. Muscle biopsy demonstrates extensive necrotizing myopathy lacking prominent inflammatory infiltrates.
A patient evaluated for recent-onset extensive cutaneous induration across the trunk and proximal extremities presents to the emergency department with a severe headache, blurred vision, blood pressure of 215/115 mmHg, and a rapidly rising serum creatinine.
An individual presents with profound, generalized hand edema ('puffy fingers'), severe digital vasospasm upon cold exposure, and exertional breathlessness. Echocardiography estimates a right ventricular systolic pressure of 55 mm Hg with normal left ventricular function and no pulmonary parenchymal disease.
A patient describes difficulty rising from low chairs, persistent dry cough, and thickened, cracked, hyperkeratotic skin on the radial aspects of the digits. High-resolution computed tomography of the chest shows bilateral basilar ground-glass opacities.

Matches

Show answer & explanation

Answer

The correct mappings associate immune-mediated necrotizing myopathy with anti-SRP, scleroderma renal crisis with anti-RNA polymerase III, Mixed Connective Tissue Disease with anti-U1-RNP, and antisynthetase syndrome with anti-Jo-1 antibodies.
Each autoantibody represents a distinct pathophysiologic entity within the rheumatologic spectrum. Anti-SRP mediates aggressive necrotizing myopathy. Anti-RNA polymerase III correlates with rapidly progressive diffuse systemic sclerosis and scleroderma renal crisis. Anti-U1-RNP defines Mixed Connective Tissue Disease with a high risk of pulmonary arterial hypertension. Anti-Jo-1 defines antisynthetase syndrome characterized by myositis, interstitial lung disease, and mechanic's hands.

Step-by-Step Solution

1
Analyze the first clinical presentation featuring massive CK elevation and necrotizing biopsy without inflammation.
Identified as immune-mediated necrotizing myopathy.
Differentiates this aggressive pathology from classic polymyositis, which typically features prominent CD8+ T-cell endomysial inflammation.
2
Evaluate the patient with diffuse skin thickening and malignant hypertension.
Identified as diffuse cutaneous systemic sclerosis complicated by scleroderma renal crisis.
Requires recognition of the specific autoantibody (anti-RNA polymerase III) conveying the highest risk for this life-threatening renal complication.
3
Assess the presentation of puffy fingers, Raynaud's, and isolated pulmonary arterial hypertension.
Identified as Mixed Connective Tissue Disease (MCTD).
The lack of parenchymal lung disease combined with these specific overlapping connective tissue features points to MCTD rather than pure systemic sclerosis.
4
Review the triad of proximal weakness, interstitial lung disease, and hyperkeratotic fingers.
Identified as antisynthetase syndrome.
The skin findings represent 'mechanic's hands', which alongside ILD and myopathy, are pathognomonic for this specific overlap syndrome driven by anti-Jo-1.

Key Concept

Advanced serologic profiling in systemic autoimmune diseases, specifically differentiating unique autoantibodies in inflammatory myopathies and scleroderma-spectrum disorders.
Estimated Time:2m 30s
Question 988Question →

A 54-year-old woman presents to the outpatient clinic reporting a three-week history of progressively worsening exertional dyspnea, fatigue, and bilateral lower extremity swelling. She states that she now requires three pillows to sleep comfortably at night without waking up short of breath. Her medical history is significant for estrogen-receptor-negative, HER2-positive breast cancer, for which she underwent surgical resection and completed a chemotherapy regimen containing doxorubicin and cyclophosphamide six months ago. She is currently receiving maintenance therapy with trastuzumab. Vital signs show a temperature of 37.1∘C37.1^\circ C (98.8∘F98.8^\circ F), heart rate of 105 /min105\text{ /min}, respiratory rate of 22 /min22\text{ /min}, and blood pressure of 114/74 mmHg114/74\text{ mmHg}. Pulse oximetry is 94%94\% on room air. Physical examination reveals an elevated jugular venous pressure of 9 cm H2O9\text{ cm H}_2\text{O}, fine bibasilar crackles, and a distinct third heart sound (S3S_3). Pitting edema is present to the mid-calves bilaterally.

Recent laboratory studies are as follows:

Laboratory TestPatient ResultReference Range
Thyroid-stimulating hormone (TSH)2.2 μU/mL2.2\text{ }\mu\text{U/mL}0.5−5.0 μU/mL0.5-5.0\text{ }\mu\text{U/mL}
Arterial pHpH7.467.467.35−7.457.35-7.45
Arterial pCO2pCO_231 mmHg31\text{ mmHg}35−45 mmHg35-45\text{ mmHg}
Arterial pO2pO_270 mmHg70\text{ mmHg}75−105 mmHg75-105\text{ mmHg}

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Transthoracic echocardiography

Answer

The most appropriate next step in management is to perform a transthoracic echocardiography.
The correct answer is transthoracic echocardiography because this patient exhibits classic signs and symptoms of acute decompensated heart failure (orthopnea, elevated JVP, S3 gallop, pulmonary crackles, and peripheral edema). Her recent treatment with doxorubicin (an anthracycline) and ongoing treatment with trastuzumab place her at an exceptionally high risk for chemotherapy-induced cardiotoxicity. Doxorubicin causes dose-dependent, irreversible myocyte necrosis leading to dilated cardiomyopathy, while trastuzumab causes a usually reversible decline in contractility. Echocardiography is the essential next step to evaluate the left ventricular ejection fraction (LVEF) and guide subsequent heart failure management.

Step-by-Step Solution

1
Identify the patient's primary clinical syndrome.
The patient presents with progressive dyspnea, orthopnea, elevated jugular venous pressure, an S3 gallop, and bilateral lower extremity edema, which are hallmark signs of acute decompensated heart failure.
Recognizing the pattern of volume overload and pump failure is required to differentiate this from primary pulmonary or endocrine pathologies.
2
Assess the patient's risk factors based on her oncologic history.
The patient received doxorubicin (an anthracycline) and is currently taking trastuzumab (a HER2 monoclonal antibody). Both are known to be highly cardiotoxic.
Anthracyclines cause dose-dependent, irreversible myocyte necrosis, while trastuzumab causes a typically reversible decline in myocardial contractility. The combination significantly amplifies the risk of dilated cardiomyopathy.
3
Determine the best diagnostic test to confirm the suspected etiology.
Transthoracic echocardiography should be ordered.
Echocardiography is the gold standard, non-invasive initial test to evaluate left ventricular ejection fraction (LVEF), structural abnormalities, and confirm the diagnosis of chemotherapy-induced cardiomyopathy.

Key Concept

Patients treated with cardiotoxic chemotherapeutic agents (e.g., anthracyclines, trastuzumab) who present with signs of volume overload must be promptly evaluated for chemotherapy-induced cardiomyopathy using transthoracic echocardiography.
Question 989Question →

A 24-year-old woman is brought to the emergency department by her roommate 2 hours after intentionally ingesting a large, unknown quantity of immediate-release acetaminophen tablets. She reports mild nausea but is otherwise asymptomatic. Her temperature is 37.0°C (98.6°F), blood pressure is 118/76 mm Hg, pulse is 88/min, and respirations are 14/min. She is alert, fully oriented, and cooperative. Arrange the following steps in the most appropriate chronological sequence for the evaluation and management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Administer oral activated charcoal, 2) Measure the serum acetaminophen concentration at 4 hours post-ingestion, 3) Determine hepatotoxicity risk using the Rumack-Matthew nomogram, 4) Initiate treatment with N-acetylcysteine if the treatment line is crossed.
The clinical management of acute immediate-release acetaminophen overdose depends heavily on the time since ingestion. Because this patient presented 2 hours post-ingestion and has a normal mental status, the first priority is gastrointestinal decontamination with oral activated charcoal, which is highly effective if given within 4 hours of ingestion. Next, a serum acetaminophen concentration must be obtained, but this should not be drawn until exactly 4 hours post-ingestion; levels drawn earlier are uninterpretable as peak absorption has not yet occurred. Once the 4-hour level is resulted, it is plotted against the time since ingestion on the Rumack-Matthew nomogram. If the plotted point falls on or above the established treatment line, the patient is at risk for severe hepatotoxicity, and the definitive antidote, N-acetylcysteine (NAC), must be administered. Because NAC is nearly 100% effective at preventing liver injury when given within 8 hours of ingestion, it is safe to wait for the 4-hour level before initiating therapy in early presenters.

Step-by-Step Solution

1
Assess the patient's airway, breathing, circulation, and mental status.
The patient has stable vital signs and is alert and cooperative, indicating that she can safely protect her airway.
Ensuring airway protection is the essential first step in any toxicology patient before administering oral decontamination therapies.
2
Determine the indication for gastrointestinal decontamination.
Oral activated charcoal is administered because the patient presented within 4 hours of an acute ingestion.
Activated charcoal binds unabsorbed acetaminophen in the gastrointestinal tract and limits systemic absorption.
3
Determine the precise timing for biochemical risk stratification.
A serum acetaminophen level is ordered to be drawn exactly at 4 hours post-ingestion.
Levels drawn before 4 hours are uninterpretable because systemic absorption and tissue distribution are not yet complete.
4
Stratify risk and determine the need for definitive antidote therapy.
The 4-hour level is plotted on the Rumack-Matthew nomogram, and N-acetylcysteine is initiated if the level indicates a high risk of hepatotoxicity.
The nomogram provides an evidence-based threshold for giving the antidote, which is maximally effective when administered within 8 hours of ingestion.

Key Concept

In the acute management of immediate-release acetaminophen overdose presenting within 4 hours, the correct sequence involves initial gastrointestinal decontamination with activated charcoal (if the airway is intact), followed by measuring the serum acetaminophen level at 4 hours post-ingestion, risk-stratifying with the Rumack-Matthew nomogram, and administering N-acetylcysteine if indicated.
Question 990Question →

Progressive shortness of breath over the past 48 hours prompts a 62-year-old man to seek evaluation at the emergency department. He has a 45-pack-year smoking history, type 2 diabetes mellitus, and essential hypertension. The patient notes that his breathing worsens significantly when he lies flat, forcing him to sleep in a recliner chair. His temperature is 37.2°C (99.0°F), blood pressure is 162/94 mm Hg, pulse is 108/min, and respiratory rate is 24/min. Pulse oximetry shows an oxygen saturation of 90% on room air. Physical examination reveals distended neck veins while sitting at a 45-degree angle. Lung auscultation demonstrates bilateral basilar crackles without wheezing. Cardiac examination reveals a regular tachycardia with a prominent S3 gallop. A chest radiograph demonstrates cardiomegaly and cephalization of pulmonary vessels. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Acute decompensated heart failure

Answer

The correct answer is acute decompensated heart failure.
The correct answer is acute decompensated heart failure. This patient presents with a classic constellation of symptoms and signs of acute biventricular heart failure. His orthopnea, bilateral basilar crackles, and S3 gallop indicate left-sided fluid overload and elevated left ventricular end-diastolic pressure. The jugular venous distention indicates right-sided fluid overload. Finally, the chest radiograph findings of cardiomegaly and cephalization (pulmonary venous congestion) definitively confirm the diagnosis over primary pulmonary pathologies.

Step-by-Step Solution

1
Identify the primary clinical syndrome based on the history.
The patient presents with acute, progressively worsening dyspnea and severe orthopnea (needing to sleep in a recliner).
Recognizing orthopnea strongly suggests a cardiogenic etiology for the dyspnea due to central fluid redistribution when supine.
2
Analyze the physical examination findings for diagnostic clues.
The exam shows jugular venous distention (right-sided fluid overload), bilateral basilar crackles (alveolar fluid), and an S3 gallop (rapid ventricular filling in a non-compliant, overloaded left ventricle).
These findings collectively indicate biventricular volume overload, distinguishing it from purely pulmonary causes of dyspnea.
3
Correlate clinical findings with the provided imaging results.
The chest radiograph shows cardiomegaly and cephalization (redistribution of blood flow to the upper lung zones).
This confirms the presence of pulmonary venous hypertension secondary to left heart failure, establishing the definitive diagnosis.

Key Concept

Diagnosis of acute decompensated heart failure hinges on identifying signs of left-sided (orthopnea, crackles, S3 gallop, cephalization) and right-sided (JVD) volume overload.
Estimated Time:1m 0s
Question 991Question →

A 65-year-old woman with a body mass index (BMI) of 32 kg/m232\text{ kg/m}^2 is diagnosed with osteoarthritis of the right knee after presenting with chronic, progressive knee pain that worsens with activity. Radiographs show joint space narrowing and osteophyte formation. Arrange the following management strategies in the standard chronological order of escalation, from initial conservative therapy to definitive treatment.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of escalating management for knee osteoarthritis begins with non-pharmacological interventions (weight loss and physical therapy), followed by first-line pharmacological therapy (NSAIDs), then intra-articular therapies (glucocorticoid injections), and finally surgical intervention (total knee arthroplasty) for refractory disease.
Osteoarthritis is managed in a stepwise fashion to minimize patient risk while maximizing symptom relief and function. Management begins with lifestyle and non-pharmacologic interventions (weight loss, exercise). If symptoms persist, first-line pharmacologic agents (topical or oral NSAIDs) are added. For continued refractory pain, localized interventions like intra-articular glucocorticoid injections are utilized. When all conservative and medical therapies fail and the patient's quality of life is severely impacted, definitive surgical management (total joint arthroplasty) is indicated.

Step-by-Step Solution

1
Identify the foundational first step for osteoarthritis management.
Weight loss, physical therapy, and low-impact exercise.
Lifestyle modifications provide significant symptom relief with minimal risk and form the basis of all osteoarthritis treatment, particularly in patients with an elevated BMI.
2
Determine the first-line escalation for persisting symptoms.
Oral or topical nonsteroidal anti-inflammatory drugs (NSAIDs).
Pharmacotherapy is introduced when lifestyle changes are insufficient. NSAIDs are the initial medications of choice.
3
Identify the next step for localized pain refractory to initial medications.
Intra-articular glucocorticoid injections.
When systemic or topical medications fail to control symptoms, targeted intra-articular injections can provide significant relief and delay the need for surgery.
4
Select the definitive treatment for end-stage, refractory disease.
Total knee arthroplasty.
Surgical intervention is considered the final step in the treatment pathway, reserved for patients who have exhausted all conservative and medical options and still have unacceptable pain and functional limitation.

Key Concept

Stepwise management of osteoarthritis
Question 992Question →

Match each of the following highly specific autoantibodies to the rheumatologic condition with which they are most classically associated.

Click a left item, then click its matching right item

Items

Anti-double-stranded DNA (Anti-dsDNA)
Anti-centromere
Anti-cyclic citrullinated peptide (Anti-CCP)
Anti-Ro/SSA

Matches

Show answer & explanation

Answer

Anti-dsDNA matches with Systemic Lupus Erythematosus; Anti-centromere matches with Limited Cutaneous Systemic Sclerosis; Anti-CCP matches with Rheumatoid Arthritis; Anti-Ro/SSA matches with Sjögren Syndrome.
Each listed autoantibody serves as a highly specific diagnostic marker for a classic rheumatologic condition. Anti-dsDNA confirms SLE. Anti-centromere confirms Limited Cutaneous Systemic Sclerosis. Anti-CCP confirms Rheumatoid Arthritis. Anti-Ro/SSA strongly supports a diagnosis of Sjögren Syndrome.

Step-by-Step Solution

1
Evaluate the clinical association for Anti-dsDNA.
Anti-dsDNA is specific for Systemic Lupus Erythematosus.
This is a core diagnostic criterion for SLE that also helps monitor disease flares.
2
Evaluate the clinical association for Anti-centromere.
Anti-centromere is specific for Limited Cutaneous Systemic Sclerosis.
It distinguishes limited cutaneous disease from diffuse cutaneous systemic sclerosis, which is typically associated with anti-Scl-70.
3
Evaluate the clinical association for Anti-CCP.
Anti-CCP is specific for Rheumatoid Arthritis.
It is more specific than Rheumatoid Factor (RF) and serves as a strong prognostic marker for erosive disease.
4
Evaluate the clinical association for Anti-Ro/SSA.
Anti-Ro/SSA is specific for Sjögren Syndrome.
These antibodies are the primary serologic markers used to support a diagnosis of primary Sjögren Syndrome.

Key Concept

Autoantibody specificities in rheumatologic diseases
Question 993Question →

A 34-year-old woman is admitted to the intensive care unit with a 2-day history of progressively worsening fatigue, fever, and confusion. Her husband notes she has been difficult to arouse this morning. Temperature is 38.2°C (100.8°F), blood pressure is 142/88 mmHg, pulse is 112/min, and respirations are 18/min. Physical examination reveals scleral icterus, pale conjunctivae, and diffuse petechiae over the lower extremities. Neurologic examination shows altered mental status but no focal motor deficits. Laboratory studies show:

Laboratory TestResult
Hemoglobin7.2 g/dL
Platelets18,000/mm³
Leukocytes9,500/mm³
Creatinine1.4 mg/dL
Lactate dehydrogenase1,200 U/L
Total bilirubin3.5 mg/dL
Indirect bilirubin2.8 mg/dL
Prothrombin time12 seconds
Partial thromboplastin time28 seconds

Thrombotic thrombocytopenic purpura (TTP) is strongly suspected. Arrange the following steps in the most appropriate chronological order for the diagnosis and management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Perform a peripheral blood smear evaluation, 2) Collect blood samples for ADAMTS13 activity, 3) Commence therapeutic plasma exchange (TPE), and 4) Taper plasma exchange frequency after platelet count normalizes.
The management of Thrombotic Thrombocytopenic Purpura (TTP) requires a strict sequence to ensure both accurate diagnosis and life-saving intervention. A peripheral blood smear is the immediate first step to confirm microangiopathic hemolytic anemia (MAHA) through the presence of schistocytes. Once MAHA is suspected in the setting of thrombocytopenia, blood for ADAMTS13 activity must be drawn. Crucially, this draw must occur before any plasma is administered to the patient, as donor plasma contains functional ADAMTS13 and will yield a false-negative assay result. Following the blood draw, therapeutic plasma exchange (TPE) must be initiated immediately; clinicians must not delay TPE while waiting for ADAMTS13 results, which often take days. Finally, TPE is continued daily and then tapered only after clinical response is achieved, indicated by normalization of platelet count and LDH.

Step-by-Step Solution

1
Confirm microangiopathic hemolytic anemia
Peripheral blood smear evaluation
Before initiating invasive treatment, visualization of schistocytes is necessary to differentiate TTP from other causes of thrombocytopenia, such as disseminated intravascular coagulation (DIC), which would typically present with prolonged coagulation times.
2
Obtain baseline enzymatic activity
Collect blood samples for ADAMTS13 activity
The ADAMTS13 assay must be drawn before introducing any donor plasma, which would falsely elevate the patient's measured ADAMTS13 levels and obscure the diagnosis.
3
Initiate lifesaving empirical therapy
Commence therapeutic plasma exchange (TPE)
TPE removes autoantibodies against ADAMTS13 and provides functional enzyme. It must be started immediately without waiting for the ADAMTS13 assay results, as untreated TTP has a mortality rate exceeding 90%.
4
Monitor response and de-escalate
Taper plasma exchange frequency after platelet count normalizes
Once the platelet count and LDH normalize, indicating the cessation of microvascular thrombosis, TPE can be gradually tapered to prevent relapse while minimizing complications.

Key Concept

The chronological diagnosis and management of Thrombotic Thrombocytopenic Purpura (TTP), emphasizing the critical timing of the ADAMTS13 assay relative to the initiation of therapeutic plasma exchange.
Question 994Question →

Seeking preconception counseling, a 26-year-old woman with a history of systemic lupus erythematosus (SLE) and class III lupus nephritis presents to the outpatient clinic. Her disease is currently in clinical and serologic remission without active proteinuria. She is maintained on a daily regimen of mycophenolate mofetil, hydroxychloroquine, and lisinopril. The patient and her husband are eager to conceive as soon as it is medically safe to do so. Arrange the following clinical steps in the optimal chronological sequence to ensure the best maternal and fetal outcomes.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1. Discontinue teratogenic agents (mycophenolate, lisinopril); 2. Initiate safe alternatives (azathioprine, nifedipine); 3. Observe for a 6-month stability period; 4. Attempt conception with close serologic monitoring; 5. Use systemic glucocorticoids as rescue therapy for any subsequent gestational flares.
The management of SLE prior to pregnancy requires a meticulous step-wise approach. Teratogens (mycophenolate mofetil and ACE inhibitors) must first be stopped. They are immediately replaced with safe alternatives (azathioprine and calcium channel blockers). Crucially, the patient must then be observed for at least 6 months to ensure the new regimen is effective at preventing a flare. Only then should conception be attempted with close monitoring. If a flare occurs during pregnancy despite these measures, systemic glucocorticoids are the safest rescue therapy.

Step-by-Step Solution

1
Identify and discontinue teratogenic maintenance medications.
Mycophenolate mofetil and lisinopril are stopped.
Mycophenolate mofetil is associated with significant congenital malformations, and ACE inhibitors like lisinopril can cause fetal renal dysgenesis.
2
Substitute with pregnancy-compatible alternatives.
Azathioprine is started for lupus nephritis maintenance, and nifedipine is started for blood pressure control.
Disease control must be maintained to prevent maternal morbidity. Azathioprine and nifedipine are well-tolerated and safe during gestation. Hydroxychloroquine is safely continued.
3
Implement a mandatory observation period.
The patient is monitored for at least 6 months on the new medication regimen.
Guidelines mandate a 6-month period of disease quiescence on pregnancy-safe medications to ensure the new regimen effectively controls the disease before conception.
4
Authorize conception and begin high-risk obstetric monitoring.
Conception is attempted, accompanied by serial lab checks (complements, anti-dsDNA, urinalysis).
Pregnancy itself can precipitate severe lupus flares. Rigorous monitoring detects subclinical flares early.
5
Establish a contingency plan for acute flares during pregnancy.
Systemic glucocorticoids are prepared as the primary rescue therapy.
If a severe flare occurs while pregnant, potent teratogens cannot be used; glucocorticoids are the safest and most effective immediate intervention.

Key Concept

Preconception management, medication sequencing, and flare treatment in Systemic Lupus Erythematosus (SLE)
Estimated Time:1m 30s
Question 995Question →

A 6262-year-old man is hospitalized due to a 44-week history of low-grade fever, progressive fatigue, and generalized myalgias. He has a history of osteoarthritis and underwent a colonoscopy 22 months ago for routine screening. His temperature is 38.3∘C38.3^\circ\text{C} (100.9∘F100.9^\circ\text{F}), blood pressure is 122/74 mm Hg122/74\text{ mm Hg}, and pulse is 92/min92/\text{min}. Physical examination reveals a grade 3/63/6 holosystolic murmur heard best at the cardiac apex that radiates to the axilla. Splinter hemorrhages are noted on the fingernails of both hands. Laboratory studies show a leukocyte count of 14,000/mm314,000/\text{mm}^3 and an erythrocyte sedimentation rate of 65 mm/hr65\text{ mm/hr}. A transesophageal echocardiogram demonstrates a 1.2-cm1.2\text{-cm} mobile vegetation on the mitral valve.

Three sets of blood cultures are drawn, and the patient is empirically started on intravenous vancomycin and ceftriaxone. Forty-eight hours later, all three blood culture sets grow *Enterococcus faecalis*. Antimicrobial susceptibility testing is reported as follows:

AntimicrobialSusceptibility
AmpicillinSusceptible
PenicillinSusceptible
VancomycinSusceptible
LinezolidSusceptible
GentamicinHigh-level resistance
StreptomycinHigh-level resistance

The patient's serum creatinine is 0.9 mg/dL0.9\text{ mg/dL}. He has no known drug allergies. Which of the following is the most appropriate next step in antimicrobial therapy?

Show answer & explanation

Answer: Intravenous ampicillin and ceftriaxone

Answer

Intravenous ampicillin and ceftriaxone
The correct answer provides the optimal definitive therapy for Enterococcus faecalis infective endocarditis with high-level aminoglycoside resistance (HLAR). Enterococci are intrinsically tolerant to many antibiotics; cell wall-active agents like ampicillin are only bacteriostatic when used alone. Eradication of vegetations in endocarditis requires bactericidal activity, which is traditionally achieved by combining ampicillin with an aminoglycoside (e.g., gentamicin). However, this patient's isolate demonstrates HLAR, meaning an aminoglycoside will not provide synergistic killing. Clinical trials have established that dual beta-lactam therapy with ampicillin and ceftriaxone is highly effective for E. faecalis endocarditis. Ceftriaxone saturates penicillin-binding proteins (PBP2 and PBP3), while ampicillin targets PBP4. Together, they achieve potent bactericidal synergy, offering a first-line alternative to aminoglycosides that also spares the patient from nephrotoxicity.

Step-by-Step Solution

1
Diagnose the clinical syndrome based on the presentation.
The patient has infective endocarditis (IE), evidenced by fever, new murmur, splinter hemorrhages, and a vegetation on echocardiography.
Establishing the severity and location of the infection dictates whether bacteriostatic or bactericidal therapy is required.
2
Interpret the microbiological data and susceptibility profile.
The pathogen is Enterococcus faecalis, which is susceptible to ampicillin but demonstrates high-level aminoglycoside resistance (HLAR) to both gentamicin and streptomycin.
Pathogen-specific susceptibility guides targeted therapy de-escalation.
3
Apply pharmacologic principles of enterococcal endocarditis treatment.
Recognize that cell-wall active agents (like ampicillin) are only bacteriostatic against enterococci. IE requires bactericidal therapy, traditionally achieved via ampicillin plus an aminoglycoside.
Bacteriostatic monotherapy is insufficient to sterilize avascular heart valve vegetations.
4
Select the appropriate alternative synergistic regimen given the HLAR.
Since HLAR precludes aminoglycoside synergy, the standard of care is dual beta-lactam therapy with ampicillin and ceftriaxone.
This combination provides synergistic bactericidal activity against E. faecalis and avoids the nephrotoxicity associated with aminoglycosides.

Key Concept

Infective endocarditis caused by Enterococcus faecalis with high-level aminoglycoside resistance (HLAR) requires targeted, synergistic bactericidal therapy with ampicillin and ceftriaxone.
Question 996Question →

A 4545-year-old woman is brought to the emergency department due to sudden-onset, severe weakness in her arms and legs. She reports she could not get out of bed this morning. She has a 33-year history of a "sand-like" sensation in her eyes, dry mouth requiring frequent sips of water, and intermittent pain in her fingers. She takes no medications. Vital signs are normal. Physical examination shows flaccid paralysis of all four extremities with absent deep tendon reflexes. Sensation is intact.

Laboratory studies show:
Serum sodium: 140 mEq/L140 \text{ mEq/L}
Serum potassium: 1.6 mEq/L1.6 \text{ mEq/L}
Serum chloride: 116 mEq/L116 \text{ mEq/L}
Serum bicarbonate: 12 mEq/L12 \text{ mEq/L}
BUN: 14 mg/dL14 \text{ mg/dL}
Creatinine: 0.9 mg/dL0.9 \text{ mg/dL}

Arterial blood gas (room air):
pH: 7.227.22
pCO 2_2: 26 mm Hg26 \text{ mm Hg}

Urinalysis:
pH: 6.56.5
Specific gravity: 1.0151.015
Glucose: negative
Protein: negative

Which of the following is the most likely underlying mechanism for this patient's acute presentation?

Show answer & explanation

Answer: Autoimmune-mediated destruction of distal tubular alpha-intercalated cells

Answer

The most likely underlying mechanism is autoimmune-mediated destruction of distal tubular alpha-intercalated cells, characteristic of Sjögren syndrome-induced Type 1 renal tubular acidosis.
The correct answer accurately describes the pathophysiology of Type 1 (distal) renal tubular acidosis (RTA) in the setting of Sjögren syndrome. This patient's history of dry eyes, dry mouth, and joint pain points to Sjögren syndrome. Her acute presentation of flaccid paralysis is driven by severe hypokalemia (1.6 mEq/L1.6 \text{ mEq/L}). Laboratory evaluation reveals a normal anion gap metabolic acidosis (anion gap =140−116−12=12 mEq/L= 140 - 116 - 12 = 12 \text{ mEq/L}). In the presence of a normal anion gap metabolic acidosis, a urine pH ≥5.5\geq 5.5 (here, 6.56.5) indicates a failure of the distal tubule to acidify the urine, confirming Type 1 RTA. Sjögren syndrome causes Type 1 RTA via autoimmune-mediated tubulointerstitial nephritis that specifically damages the alpha-intercalated cells of the cortical collecting duct, impairing hydrogen ion secretion and leading to profound secondary potassium wasting.

Step-by-Step Solution

1
Identify the primary rheumatologic syndrome from the patient's history.
The patient has chronic sicca symptoms (dry eyes, dry mouth) and polyarthralgia, which are classic clinical features of Sjögren syndrome.
Establishing the underlying systemic autoimmune disease provides the necessary context for the acute metabolic derangement.
2
Analyze the acid-base and electrolyte status.
The patient has acidemia (pH 7.227.22). The anion gap is calculated as Na+−(Cl−+HCO3−)=140−(116+12)=12 mEq/LNa^+ - (Cl^- + HCO_3^-) = 140 - (116 + 12) = 12 \text{ mEq/L}. This confirms a normal anion gap metabolic acidosis (NAGMA).
Differentiating between anion gap and normal anion gap metabolic acidosis is the first essential step in determining the etiology of the acid-base disorder.
3
Assess the appropriateness of respiratory compensation using Winter's formula.
Expected pCO2=(1.5×12)+8=26±2pCO_2 = (1.5 \times 12) + 8 = 26 \pm 2. The measured pCO2pCO_2 is exactly 26 mm Hg26 \text{ mm Hg}, indicating appropriate respiratory compensation with no concurrent respiratory disorder.
This rules out mixed acid-base disorders and confirms a pure metabolic acidosis.
4
Diagnose the specific cause of the NAGMA.
The patient has a NAGMA, severe hypokalemia (1.6 mEq/L1.6 \text{ mEq/L}), and an inappropriately alkaline urine (pH 6.56.5) despite severe systemic acidemia. This triad is highly specific for Type 1 (distal) renal tubular acidosis (RTA).
The distal tubule's failure to secrete hydrogen ions results in inappropriately elevated urine pH (≥5.5\geq 5.5) and profound potassium wasting.
5
Synthesize the pathophysiology.
Sjögren syndrome is a well-known cause of Type 1 RTA due to autoantibody-mediated lymphocytic infiltration and destruction of the alpha-intercalated cells in the distal collecting duct.
This connects the patient's rheumatologic diagnosis to the acute presentation of hypokalemic paralysis.

Key Concept

Sjögren syndrome can manifest with extra-glandular renal involvement, classically presenting as Type 1 (distal) renal tubular acidosis due to autoantibody-mediated destruction of alpha-intercalated cells, leading to severe hypokalemia and normal anion gap metabolic acidosis.
Question 997Question →

A 3434-year-old female teacher comes to the primary care office complaining of severe throat pain and a fever that began abruptly yesterday. She notes difficulty swallowing but denies having a cough or rhinorrhea. Her temperature is 38.7∘C38.7^\circ\text{C} (101.7∘F101.7^\circ\text{F}), blood pressure is 118/76 mmHg118/76\text{ mmHg}, and pulse is 92/min92/\text{min}. Physical examination reveals marked pharyngeal erythema, bilateral tonsillar exudates, and tender anterior cervical lymphadenopathy. A rapid antigen detection test is positive for Streptococcus pyogenes (Group A Streptococcus). The patient has no known drug allergies. Which of the following is the most appropriate next step in pharmacologic management?

Show answer & explanation

Answer: Prescribe oral penicillin V

Answer

The most appropriate pharmacologic management for this patient is to prescribe oral penicillin V.
The correct option identifies the optimal narrow-spectrum antibiotic therapy. Group A Streptococcus (GAS) is universally susceptible to beta-lactam antibiotics. In a patient with no reported medication allergies, oral penicillin V (or oral amoxicillin) is the established standard first-line treatment. This targeted approach efficiently eradicates the organism, shortens the duration of symptoms, prevents the serious complication of acute rheumatic fever, and aligns perfectly with the principles of antimicrobial stewardship by strictly avoiding unnecessarily broad coverage.

Step-by-Step Solution

1
Evaluate the clinical presentation and diagnostic test results.
The patient has symptomatic acute pharyngitis with a positive rapid antigen test confirming Group A Streptococcus (GAS) infection.
Confirming the exact bacterial etiology determines the necessity and specific target of antimicrobial therapy.
2
Select the appropriate antibiotic based on efficacy and antimicrobial stewardship principles.
Oral penicillin V (or amoxicillin) is chosen as the first-line treatment.
GAS remains universally susceptible to penicillin. Using this narrow-spectrum agent effectively eradicates the infection, prevents acute rheumatic fever, and avoids unnecessarily selecting for resistant organisms.

Key Concept

The standard first-line treatment for Group A Streptococcal pharyngitis in a patient without medication allergies is a narrow-spectrum penicillin or amoxicillin to ensure clinical efficacy while maintaining proper antibiotic stewardship.
Question 998Question →

A 58-year-old man comes to the urgent care clinic complaining of severe left knee pain that awoke him from sleep. He has a medical history of hypertension and heart failure with preserved ejection fraction, for which he takes lisinopril and hydrochlorothiazide. His temperature is 37.9∘C37.9^\circ\text{C} (100.2∘F100.2^\circ\text{F}). Physical examination reveals a swollen, erythematous, and exquisitely tender left knee with limited range of motion. There are no other joint abnormalities. Laboratory testing reveals a serum uric acid level of 5.8 mg/dL5.8 \text{ mg/dL} (reference: 4.0−8.5 mg/dL4.0-8.5 \text{ mg/dL}). A diagnostic arthrocentesis is performed; synovial fluid analysis shows a leukocyte count of 42,000/mm342,000/\text{mm}^3 with 85%85\% neutrophils, and the presence of needle-shaped, negatively birefringent crystals. Gram stain reveals no organisms. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intra-articular injection of a glucocorticoid

Answer

Intra-articular injection of a glucocorticoid
The patient's presentation of acute, severe monoarticular joint pain with warmth, swelling, and erythema, combined with synovial fluid demonstrating needle-shaped, negatively birefringent crystals, is diagnostic of an acute gout flare. The acute attack was likely triggered by the recent initiation of a thiazide diuretic (hydrochlorothiazide), which decreases renal urate excretion. While NSAIDs and colchicine are typical first-line treatments for acute gout, this patient has a history of heart failure with preserved ejection fraction; NSAIDs can exacerbate heart failure by causing fluid retention and should generally be avoided in these patients. Intra-articular glucocorticoid injection is highly effective for monoarticular gout, provides rapid relief, and minimizes systemic side effects, making it the most appropriate next step in management.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and synovial fluid results.
The patient has acute monoarthritis with needle-shaped, negatively birefringent crystals and a leukocyte count of 42,000/mm342,000/\text{mm}^3, confirming acute gout.
Synovial fluid crystal analysis is the gold standard for diagnosing crystal arthropathies and differentiating them from septic arthritis.
2
Evaluate the patient's comorbidities and current medications.
The patient has heart failure with preserved ejection fraction and is taking hydrochlorothiazide, which likely precipitated the gout flare.
Comorbidities dictate the choice of therapy. NSAIDs are typically first-line for gout but are contraindicated or highly cautioned in heart failure due to the risk of fluid retention and acute decompensation.
3
Select the safest and most effective targeted therapy for the acute flare.
Intra-articular glucocorticoids are selected over systemic NSAIDs or systemic steroids.
Intra-articular injection provides localized, rapid anti-inflammatory effects while minimizing the systemic adverse effects associated with NSAIDs or systemic corticosteroids in a patient with heart failure.

Key Concept

The diagnosis of acute gout is confirmed by the presence of negatively birefringent monosodium urate crystals in the synovial fluid. Serum uric acid levels may be normal during an acute flare. Intra-articular glucocorticoids are the preferred treatment for acute monoarticular gout in patients with contraindications to NSAIDs, such as heart failure.
Question 999Question →

Match each classic peripheral blood smear or bone marrow finding to its most likely associated hematologic diagnosis.

Click a left item, then click its matching right item

Items

Auer rods
Smudge cells
Howell-Jolly bodies
Bite cells and Heinz bodies

Matches

Show answer & explanation

Answer

Auer rods indicate Acute myeloid leukemia; Smudge cells indicate Chronic lymphocytic leukemia; Howell-Jolly bodies indicate Sickle cell disease; Bite cells and Heinz bodies indicate Glucose-6-phosphate dehydrogenase deficiency.
Each peripheral smear finding is a classic hallmark of its respective disease process, reflecting the underlying pathophysiology such as cell fragility, absent splenic pitting, or specific intracellular inclusions.

Step-by-Step Solution

1
Identify the lineage and pathogenesis associated with Auer rods.
Auer rods are pathognomonic for myeloblasts.
They consist of fused primary granules seen in acute myeloid leukemia.
2
Determine the origin of smudge cells on a peripheral smear.
Smudge cells represent fragile neoplastic lymphocytes.
This extreme fragility is a classic hallmark of chronic lymphocytic leukemia.
3
Recall the physiologic mechanism of splenic pitting regarding red blood cell inclusions.
The spleen removes nuclear remnants known as Howell-Jolly bodies.
Sickle cell disease leads to autoinfarction and functional asplenia, allowing these bodies to remain in circulation.
4
Correlate bite cells and Heinz bodies with their underlying metabolic defect.
These inclusions occur due to oxidative damage to hemoglobin.
Glucose-6-phosphate dehydrogenase deficiency impairs the red blood cell's ability to resist oxidative stress.

Key Concept

Classic pathognomonic findings on peripheral blood smears are essential for identifying specific hematologic malignancies and red blood cell disorders.
Question 1000Question →

A 3434-year-old woman comes to the outpatient medical clinic reporting a 66-month history of progressive fatigue, weakness, and a 4.5 kg4.5\ \text{kg} (10 lb10\ \text{lb}) weight gain. She notes that her menstrual periods, which were previously regular, have ceased entirely over the same timeframe. She takes no medications and has no other medical history. Vital signs show a temperature of 36.4∘C36.4^\circ\text{C} (97.5∘F97.5^\circ\text{F}), pulse of 54/min54/\text{min}, and blood pressure of 100/65 mm Hg100/65\ \text{mm Hg}. Physical examination reveals dry skin and a delayed relaxation phase of the deep tendon reflexes. The thyroid gland is not palpable. A urine pregnancy test is negative.

Laboratory results are as follows:

Laboratory TestResultReference Range
Thyroid-stimulating hormone (TSH)1.2 μU/mL1.2\ \mu\text{U/mL}0.5−5.0 μU/mL0.5-5.0\ \mu\text{U/mL}
Free thyroxine (T4)0.4 ng/dL0.4\ \text{ng/dL}0.9−2.4 ng/dL0.9-2.4\ \text{ng/dL}

Which of the following is the most appropriate next step in the evaluation of this patient?

Show answer & explanation

Answer: Magnetic resonance imaging of the brain

Answer

Magnetic resonance imaging of the brain is the most appropriate next step to evaluate for a structural pituitary lesion causing central hypothyroidism.
The correct answer is magnetic resonance imaging of the brain. The patient's presentation of fatigue, weight gain, bradycardia, and delayed reflexes strongly suggests hypothyroidism, which is confirmed by the low free T4. However, her TSH is inappropriately normal. In primary hypothyroidism (thyroid gland failure), the loss of negative feedback leads to a high TSH. A low T4 with a low or normal TSH indicates central hypothyroidism, which stems from insufficient TSH production by the anterior pituitary gland or insufficient TRH from the hypothalamus. Her concurrent amenorrhea indicates a deficiency in gonadotropins (LH/FSH), further suggesting a compressive structural lesion in the pituitary, such as a macroadenoma. Therefore, the best next step is an MRI of the brain to visualize the sella turcica.

Step-by-Step Solution

1
Interpret the thyroid function tests in the context of the patient's symptoms.
The patient has clinical hypothyroidism with a low free T4, but the TSH is inappropriately normal rather than elevated.
This pattern distinguishes central (secondary) hypothyroidism from primary hypothyroidism, indicating a failure of the pituitary or hypothalamus.
2
Synthesize the laboratory findings with the clinical history of amenorrhea.
The combination of central hypothyroidism and secondary amenorrhea points to a global anterior pituitary dysfunction, likely due to a mass lesion.
Multiple anterior pituitary hormone deficiencies strongly suggest structural pituitary disease, such as a non-functioning pituitary adenoma or prolactinoma.
3
Determine the most appropriate next step in evaluation.
Order a magnetic resonance imaging (MRI) of the brain.
An MRI is required to visualize the pituitary gland and hypothalamus to identify any structural causes before initiating hormone replacement therapy.

Key Concept

Central (secondary) hypothyroidism is characterized by a low free T4 and an inappropriately normal or low TSH. Evaluation requires an MRI of the brain to rule out structural pituitary lesions, and concurrent adrenal insufficiency must be excluded before starting levothyroxine.
PreviousPage 50 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 50 | Examkin